Home 
Bratislava Medical Journal 2024 Bratislava Medical Journal Vol.125, No.6, p.382–386, 2024
Bratislava Medical Journal 2024 Bratislava Medical Journal Vol.125, No.6, p.382–386, 2024
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.125, No.6, p.382–386, 2024 |
||
| Title: Is increased activator protein 1 in cerebrospinal fluid as a potential biomarker that distinguishes idiopathic intracranial hypertension from multiple sclerosis? | ||
| Author: Seyda KARABORK, Humeyra CELIK, Ali Dogan DURSUN, Handan ANKARALI, Sule Aydin TURKOGLU | ||
| Abstract: OBJECTIVES: To distinguish whether idiopathic intracranial hypertension (IIH) is a condition predisposing to multiple sclerosis (MS) or an isolated disease, the current gene transcription factor Activator Protein-1 (AP-1) was evaluated with its potential to differentiate both diseases. BACKGROUND: The aim of this study was to investigate the use of AP-1 as biomarkers for the discrimination of IIH and MS. METHODS: AP-1, TNF-α, and IL-6 protein values in the CSF of the cases were evaluated by the ELISA method. The numerical measures of the groups and the ability of AP-1 to distinguish the groups were analyzed with the ROC curve. RESULTS: There was no difference between the groups in CSF TNF-α, IL-6, CSF, and serum biochemistry analyses. However, it was determined that the AP-1 concentration (pg/ml) was significantly higher in the IIH group, the sensitivity of AP-1 in separating those with IIH was 75%, and the specificity in separating those with MS was 60% in those with an AP-1 concentration of 606.5 and above. CONCLUSION: According to our results, the fact that CSF TNF-α and IL-6 values did not differ in IIH compared to MS revealed that IIH could not methodologically control MS, and AP-1 was a supportive parameter in differentiating both diseases (Tab. 2, Fig. 1, Ref. 31). |
||
| Keywords: multiple sclerosis, idiopatic intracranial hypertension, activator protein-1, cerebrospinal fluid, inflammation | ||
| Published online: 12-Mar-2024 | ||
| Year: 2024, Volume: 125, Issue: 6 | Page From: 382, Page To: 386 | |
| doi:10.4149/BLL_2024_58 |
||
|
|
 download file |
|